Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombosis of Portal Venous System.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04173429
What this trial is testing

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Qilu Hospital of Shandong University 64
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Testing effectiveness (Phase 2)Study completedNCT01911000
What this trial is testing

Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis

Who this might be right for
Carcinoma. Hepatocellular
Samsung Medical Center 69
Not applicableStudy completedNCT03427164
What this trial is testing

Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure

Who this might be right for
Portal Hypertension
University of Kansas Medical Center 30
Large-scale testing (Phase 3)UnknownNCT03192644
What this trial is testing

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 162
Large-scale testing (Phase 3)UnknownNCT02971345
What this trial is testing

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Shanghai Zhongshan Hospital 253
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Large-scale testing (Phase 3)Study completedNCT02585713
What this trial is testing

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisGonadal Thrombosis+9 more
Academic and Community Cancer Research United 300
Large-scale testing (Phase 3)Ended earlyNCT01887717
What this trial is testing

Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 36
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Not applicableStudy completedNCT06005883
What this trial is testing

Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisPrognosis
Keimyung University Dongsan Medical Center 332
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Post-approval studies (Phase 4)Study completedNCT04645550
What this trial is testing

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）

Who this might be right for
CirrhosisSplenectomy; StatusVenous Thrombosis+1 more
Northern Jiangsu People's Hospital 120
Not applicableUnknownNCT06319131
What this trial is testing

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Who this might be right for
Portal Vein Thrombosis
Shanghai Zhongshan Hospital 84
Testing effectiveness (Phase 2)Looking for participantsNCT06166576
What this trial is testing

Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 30
Not applicableUnknownNCT04433481
What this trial is testing

Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Institute of Liver and Biliary Sciences, India 84
Not applicableUnknownNCT06061445
What this trial is testing

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Who this might be right for
Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital 22
Not applicableStudy completedNCT05304455
What this trial is testing

Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection

Who this might be right for
CirrhosisSplenectomyVenous Thrombosis+1 more
Northern Jiangsu People's Hospital 40
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07122089
What this trial is testing

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis 80
Next Page